Detalhe da pesquisa
1.
In vivo evolution of a Klebsiella pneumoniae capsule defect with wcaJ mutation promotes complement-mediated opsono-phagocytosis during recurrent infection.
J Infect Dis;
2024 Jan 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38271564
2.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.
Clin Infect Dis;
78(2): 248-258, 2024 02 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37738153
3.
In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals.
Antimicrob Agents Chemother;
68(3): e0125823, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38289078
4.
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
J Antimicrob Chemother;
79(4): 801-809, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38334390
5.
Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care Unit.
Clin Infect Dis;
76(3): e1261-e1265, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35974429
6.
Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients.
J Antimicrob Chemother;
78(4): 1034-1040, 2023 04 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36869724
7.
Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri.
Antimicrob Agents Chemother;
65(7): e0015021, 2021 06 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33972237
8.
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime.
Clin Infect Dis;
71(10): 2713-2716, 2020 12 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32236408
9.
KPC-3-Producing Serratia marcescens Outbreak between Acute and Long-Term Care Facilities, Florida, USA.
Emerg Infect Dis;
26(11): 2746-2750, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33079055
10.
Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion.
Antimicrob Agents Chemother;
64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32284381
11.
High-Level Carbapenem Resistance in OXA-232-Producing Raoultella ornithinolytica Triggered by Ertapenem Therapy.
Antimicrob Agents Chemother;
64(1)2019 12 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31636064
12.
Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258.
J Antimicrob Chemother;
74(8): 2203-2208, 2019 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31127290
13.
In vivo evolution of a Klebsiella pneumoniae capsule defect promotes complement-mediated opsono-phagocytosis and persistence during recurrent infection.
bioRxiv;
2023 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37398264
14.
IS26-mediated plasmid reshuffling results in convergence of toxin-antitoxin systems but loss of resistance genes in XDR Klebsiella pneumoniae from a chronic infection.
Microb Genom;
8(9)2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36169644
15.
Isolation and Characterization of Lytic Bacteriophages Targeting Diverse Enterobacter spp. Clinical Isolates.
Phage (New Rochelle);
3(1): 50-58, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36147219
16.
Genomic characterization of lytic bacteriophages targeting genetically diverse Pseudomonas aeruginosa clinical isolates.
iScience;
25(6): 104372, 2022 Jun 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35620437
17.
Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance.
mBio;
13(2): e0275921, 2022 04 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35311529
18.
In Vitro Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirA.
Microbiol Spectr;
9(3): e0177921, 2021 12 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34756080
19.
Rasamsonia sp: An emerging infection amongst chronic granulomatous disease patients. A case of disseminated infection by a putatively novel Rasamsonia argillacea species complex involving the heart.
Med Mycol Case Rep;
24: 54-57, 2019 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31032179
20.
Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.
Expert Rev Anti Infect Ther;
16(2): 89-110, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29310479